Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines.

Ozretić P, Hanžić N, Proust B, Sabol M, Trnski D, Radić M, Musani V, Ciribilli Y, Milas I, Puljiz Z, Bosnar MH, Levanat S, Slade N.

Sci Rep. 2019 Aug 28;9(1):12470. doi: 10.1038/s41598-019-48882-y.

2.

The role of p53 isoforms' expression and p53 mutation status in renal cell cancer prognosis.

Knezović Florijan M, Ozretić P, Bujak M, Pezzè L, Ciribilli Y, Kaštelan Ž, Slade N, Hudolin T.

Urol Oncol. 2019 Sep;37(9):578.e1-578.e10. doi: 10.1016/j.urolonc.2019.03.007. Epub 2019 Apr 2.

PMID:
30948335
3.

Syntheses of gold nanoparticles and their impact on the cell cycle in breast cancer cells subjected to megavoltage X-ray irradiation.

Hanžić N, Horvat A, Bibić J, Unfried K, Jurkin T, Dražić G, Marijanović I, Slade N, Gotić M.

Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:486-495. doi: 10.1016/j.msec.2018.05.066. Epub 2018 May 22.

PMID:
30033280
4.

The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.

Jazvinšćak Jembrek M, Slade N, Hof PR, Šimić G.

Prog Neurobiol. 2018 Sep;168:104-127. doi: 10.1016/j.pneurobio.2018.05.001. Epub 2018 May 4. Review.

PMID:
29733887
5.

Mechanisms of fetal epigenetics that determine telomere dynamics and health span in adulthood.

Ravlić S, Škrobot Vidaček N, Nanić L, Laganović M, Slade N, Jelaković B, Rubelj I.

Mech Ageing Dev. 2018 Sep;174:55-62. doi: 10.1016/j.mad.2017.08.014. Epub 2017 Aug 26. Review.

PMID:
28847485
6.

Suppression of Smad-1 mRNA expression level by Smad-2 likely control dichotomy of NF-κB and Smads mediated activation.

Slade N, Zorić A, Horvat B, Vukšić M, Kostović I, Poljak L.

Immunobiology. 2015 Jan;220(1):48-53. doi: 10.1016/j.imbio.2014.09.003. Epub 2014 Sep 16.

PMID:
25261891
7.

Reduced telomere length is not associated with early signs of vascular aging in young men born after intrauterine growth restriction: a paradox?

Laganović M, Bendix L, Rubelj I, Kirhmajer MV, Slade N, Lela IV, Premužić V, Nilsson PM, Jelaković B.

J Hypertens. 2014 Aug;32(8):1613-19; discussion 1619-20. doi: 10.1097/HJH.0000000000000217.

PMID:
24805953
8.

Detection and plant monitoring programs: lessons from an intensive survey of Asclepias meadii with five observers.

Alexander HM, Reed AW, Kettle WD, Slade NA, Bodbyl Roels SA, Collins CD, Salisbury V.

PLoS One. 2012;7(12):e52762. doi: 10.1371/journal.pone.0052762. Epub 2012 Dec 20.

9.

Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis.

Zorić A, Horvat A, Slade N.

Carcinogenesis. 2013 Mar;34(3):522-9. doi: 10.1093/carcin/bgs370. Epub 2012 Nov 27.

PMID:
23188674
10.

Buffering and plasticity in vital rates of oldfield rodents.

Reed AW, Slade NA.

J Anim Ecol. 2012 Sep;81(5):953-9. doi: 10.1111/j.1365-2656.2012.01976.x. Epub 2012 Feb 29.

PMID:
22375923
11.

Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.

Jelaković B, Karanović S, Vuković-Lela I, Miller F, Edwards KL, Nikolić J, Tomić K, Slade N, Brdar B, Turesky RJ, Stipančić Ž, Dittrich D, Grollman AP, Dickman KG.

Kidney Int. 2012 Mar;81(6):559-67. doi: 10.1038/ki.2011.371. Epub 2011 Nov 9.

12.

TP53 Mutational signature for aristolochic acid: an environmental carcinogen.

Moriya M, Slade N, Brdar B, Medverec Z, Tomic K, Jelaković B, Wu L, Truong S, Fernandes A, Grollman AP.

Int J Cancer. 2011 Sep 15;129(6):1532-6. doi: 10.1002/ijc.26077. Epub 2011 Jun 9.

13.

Targeting p73--a potential approach in cancer treatment.

Slade N, Horvat A.

Curr Pharm Des. 2011;17(6):591-602. Review.

PMID:
21391909
14.

Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.

Hofstetter G, Berger A, Fiegl H, Slade N, Zorić A, Holzer B, Schuster E, Mobus VJ, Reimer D, Daxenbichler G, Marth C, Zeimet AG, Concin N, Zeillinger R.

Oncogene. 2010 Apr 1;29(13):1997-2004. doi: 10.1038/onc.2009.482. Epub 2010 Jan 18.

PMID:
20101229
15.

p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Slade N, Moll UM, Brdar B, Zorić A, Jelaković B.

Mutat Res. 2009 Apr 26;663(1-2):1-6. doi: 10.1016/j.mrfmmm.2009.01.005. Epub 2009 Feb 4. Review.

16.

The effect of aprotinin on risk of acute renal failure requiring dialysis after on-pump cardiac surgery.

Raajkumar A, Ho KM, Cokis C, Slade N.

Anaesth Intensive Care. 2008 May;36(3):374-8.

17.

Density-dependent recruitment in grassland small mammals.

Reed AW, Slade NA.

J Anim Ecol. 2008 Jan;77(1):57-65. Epub 2007 Nov 26.

PMID:
18039321
18.

Aristolochic acid and the etiology of endemic (Balkan) nephropathy.

Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelić M, Jelaković B.

Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12129-34. Epub 2007 Jul 9.

19.

Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.

Becker K, Pancoska P, Concin N, Vanden Heuvel K, Slade N, Fischer M, Chalas E, Moll UM.

Int J Oncol. 2006 Oct;29(4):889-902.

PMID:
16964385
20.

p63 and p73: roles in development and tumor formation.

Moll UM, Slade N.

Mol Cancer Res. 2004 Jul;2(7):371-86. Review.

21.

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.

Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, Daxenbichler G, Zeimet A, Zeillinger R, Marth C, Moll UM.

Cancer Res. 2004 Apr 1;64(7):2449-60.

22.

DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation.

Slade N, Zaika AI, Erster S, Moll UM.

Cell Death Differ. 2004 Mar;11(3):357-60. No abstract available.

23.

Novel derivatives of benzo[b]thieno[2,3-c]quinolones: synthesis, photochemical synthesis, and antitumor evaluation.

Dogan Koruznjak J, Grdisa M, Slade N, Zamola B, Pavelić K, Karminski-Zamola G.

J Med Chem. 2003 Oct 9;46(21):4516-24.

PMID:
14521413
24.

Synthesis, structural studies, and biological evaluation of some purine substituted 1-aminocyclopropane-1-carboxylic acids and 1-amino-1-hydroxymethylcyclopropanes.

Dzolić Z, Kristafor V, Cetina M, Nagl A, Hergold-Brundić A, Mrvos-Sermek D, Burgemeister T, Grdisa M, Slade N, Pavelić K, Balzarini J, De Clercq E, Mintas M.

Nucleosides Nucleotides Nucleic Acids. 2003 Apr;22(4):373-89.

PMID:
12885120
25.

Mutational analysis of p53 in human tumors: immunocytochemistry.

Slade N, Moll UM.

Methods Mol Biol. 2003;234:231-43.

PMID:
12824536
26.

Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP.

Erster S, Slade N, Moll UM.

Methods Mol Biol. 2003;234:219-30.

PMID:
12824535
27.

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.

Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM.

J Exp Med. 2002 Sep 16;196(6):765-80.

28.

Synthesis, photochemical synthesis and antitumor evaluation of novel derivatives of thieno[3',2':4,5]thieno[2,3-c]quinolones.

DoganKoruznjak J, Slade N, Zamola B, Pavelić K, Karminski-Zamola G.

Chem Pharm Bull (Tokyo). 2002 May;50(5):656-60.

29.
30.

Effects of habitat destruction and resource supplementation in a predator-prey metapopulation model.

Swihart RK, Feng Z, Slade NA, Mason DM, Gehring TM.

J Theor Biol. 2001 Jun 7;210(3):287-303.

PMID:
11397130
31.

Expression of erbB-3 protein in colorectal adenocarcinoma: correlation with poor survival.

Kapitanović S, Radosević S, Slade N, Kapitanović M, Andelinović S, Ferencić Z, Tavassoli M, Spaventi S, Pavelić K, Spaventi R.

J Cancer Res Clin Oncol. 2000 Apr;126(4):205-11.

PMID:
10782893
32.

Effect of extracellular NADH on human tumor cell proliferation.

Slade N, Storga-Tomic D, Birkmayer GD, Pavelic K, Pavelic J.

Anticancer Res. 1999 Nov-Dec;19(6B):5355-60.

PMID:
10697561
33.

Legal standards and the significance of DNA evidence.

Gomulkiewicz R, Slade NA.

Hum Biol. 1997 Oct;69(5):675-88.

PMID:
9299887
34.
35.

A Bayesian approach to the inference of diploid genotypes using haploid genotypes.

Alexander HM, Slade NA, Gomulkiewicz R.

Theor Appl Genet. 1995 Dec;91(8):1284-7. doi: 10.1007/BF00220942.

PMID:
24170059
36.

Type IV collagenase in squamous cell and basal cell skin carcinomas.

Slade N, Pavelić J, Kurslin B, Pavelić K.

Arch Dermatol Res. 1995;287(5):512-4. No abstract available.

PMID:
7625865
37.

p185neu is expressed in yolk sac during rat postimplantation development.

Knezevic V, Spaventi R, Poljak L, Slade N, Svajger A, Pavelic K.

J Anat. 1994 Aug;185 ( Pt 1):181-7.

38.

Collagenase derived from human fibrosarcoma is responsible for degradation of basement membranes.

Slade N, Levanat S, Spaventi S, Pavelić K.

Int J Exp Pathol. 1991 Dec;72(6):715-24.

39.

A new procedure for the cryopreservation of equine embryos.

Slade NP, Takeda T, Squires EL, Elsden RP, Seidel GE Jr.

Theriogenology. 1985 Jul;24(1):45-58.

PMID:
16726058
40.

Localized amyloid of the ureter--case report and review of the literature.

Farrands PA, Tribe CR, Slade N.

Histopathology. 1983 Jul;7(4):613-22.

PMID:
6885003
41.

Fractionation and turnover of stable carbon isotopes in animal tissues: Implications for δ13C analysis of diet.

Tieszen LL, Boutton TW, Tesdahl KG, Slade NA.

Oecologia. 1983 Mar;57(1-2):32-37. doi: 10.1007/BF00379558.

PMID:
28310153
42.

Arterial embolisation in renal carcinoma: a useful procedure?

Teasdale C, Kirk D, Jeans WD, Penry JB, Tribe CT, Slade N.

Br J Urol. 1982 Dec;54(6):616-9.

PMID:
7150911
43.

Intravascular complications of transurethral resection of the prostate.

Bird D, Slade N, Feneley RC.

Br J Urol. 1982 Oct;54(5):564-5. No abstract available.

PMID:
7171964
44.

The role of palliative urinary diversion in the management of bladder cancer.

Kirk D, Slade N, Feneley RC.

Br J Urol. 1982 Aug;54(4):363-5. No abstract available.

PMID:
6180792
45.

Franzen-positive carcinoma of the prostate in histologically benign glands.

Swift AC, Slade N, Gingell JC.

Cancer Detect Prev. 1982;5(2):195-200. No abstract available.

PMID:
6181875
46.

Postoperative urinary tract infections in urology and gynaecology: a review.

Slade N.

J R Soc Med. 1980 Oct;73(10):739-43. No abstract available.

47.
48.

The long-term results of ileal conduit urinary diversion in children.

Dunn M, Roberts JB, Smith PJ, Slade N.

Br J Urol. 1979 Dec;51(6):458-61.

PMID:
534825
49.

A predator--prey viewpoint of a single species population.

Ross GG, Slade NA.

J Theor Biol. 1979 Apr 21;77(4):513-22. No abstract available.

PMID:
491695
50.

The management of vesicoureteric reflux in children.

Dunn M, Slade N, Gumpert JR, Smith PJ, Dounis A.

Br J Urol. 1978 Dec;50(7):474-8.

PMID:
753496

Supplemental Content

Support Center